Motivation for Smoking Cessation in Patients With Oral Squamous Cell Carcinoma—A One-Time Survey

IF 2.2 Q3 DENTISTRY, ORAL SURGERY & MEDICINE

Clinical and Experimental Dental Research Pub Date : 2025-08-11 DOI:10.1002/cre2.70154

Lennart Johannes Gruber, Matthias Maximilian Bühler, Antonie Spillner, Stefan Andreas, Philipp Kauffmann, Henning Schliephake, Susanne Wolfer

{"title":"Motivation for Smoking Cessation in Patients With Oral Squamous Cell Carcinoma—A One-Time Survey","authors":"Lennart Johannes Gruber, Matthias Maximilian Bühler, Antonie Spillner, Stefan Andreas, Philipp Kauffmann, Henning Schliephake, Susanne Wolfer","doi":"10.1002/cre2.70154","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>Tobacco smoking is one major risk factor in the development of oral squamous cell carcinoma (OSCC). Continuation of smoking after diagnosis and treatment is associated with an increase in recurrence rate and incidence of second tumors, with a shorter lon g-term survival and poorer response to therapy. In the current German guideline for the treatment of OSCC, there is no clear recommendation to participate in structured smoking cessation programs.</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>A total of 202 patients with histologically confirmed OSCC completed a one-time assessment of their smoking behavior using three standardized questionnaires during regular tumor follow-up. In addition to sociodemographic data, patients were asked retrospectively about their smoking habits and motivation to quit smoking before and after diagnosis and treatment.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A serious smoking cessation attempt before diagnosis of OSCC were stated in 54.8% of the participants. This number increased up to 82.2% after OSCC diagnosis. However, only 48.5% managed to quit smoking after diagnosis. Professional support was with only 21.92% (<i>n</i> = 16) rarely used. Motivation to quit was significantly lower before (2.75 ± 2.41) than after OSCC diagnosis (7.27 ± 2.41) (<i>p</i> = 0.001) and significantly higher among the participants who finally managed to quit (9.38 ± 1.68) than among those who continued smoking (4.79 ± 3.43) (<i>p</i> = 0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The diagnosis of OSCC appears to be an important teachable moment for smoking cessation. To maximize this effect, an early and standardized implementation of systematic smoking cessation programs into the therapeutic concept of patients with OSCC is strongly recommended.</p>\n </section>\n </div>","PeriodicalId":10203,"journal":{"name":"Clinical and Experimental Dental Research","volume":"11 4","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cre2.70154","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dental Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cre2.70154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

Tobacco smoking is one major risk factor in the development of oral squamous cell carcinoma (OSCC). Continuation of smoking after diagnosis and treatment is associated with an increase in recurrence rate and incidence of second tumors, with a shorter lon g-term survival and poorer response to therapy. In the current German guideline for the treatment of OSCC, there is no clear recommendation to participate in structured smoking cessation programs.

Materials and Methods

A total of 202 patients with histologically confirmed OSCC completed a one-time assessment of their smoking behavior using three standardized questionnaires during regular tumor follow-up. In addition to sociodemographic data, patients were asked retrospectively about their smoking habits and motivation to quit smoking before and after diagnosis and treatment.

Results

A serious smoking cessation attempt before diagnosis of OSCC were stated in 54.8% of the participants. This number increased up to 82.2% after OSCC diagnosis. However, only 48.5% managed to quit smoking after diagnosis. Professional support was with only 21.92% (n = 16) rarely used. Motivation to quit was significantly lower before (2.75 ± 2.41) than after OSCC diagnosis (7.27 ± 2.41) (p = 0.001) and significantly higher among the participants who finally managed to quit (9.38 ± 1.68) than among those who continued smoking (4.79 ± 3.43) (p = 0.001).

Conclusions

The diagnosis of OSCC appears to be an important teachable moment for smoking cessation. To maximize this effect, an early and standardized implementation of systematic smoking cessation programs into the therapeutic concept of patients with OSCC is strongly recommended.

Abstract Image

查看原文本刊更多论文

口腔鳞状细胞癌患者戒烟动机的一次性调查

目的吸烟是口腔鳞状细胞癌（OSCC）发生的主要危险因素之一。诊断和治疗后继续吸烟与复发率和第二肿瘤发生率增加有关，长期生存时间较短，治疗反应较差。在目前的德国OSCC治疗指南中，没有明确建议参加有组织的戒烟计划。材料与方法对202例经组织学证实的OSCC患者在定期肿瘤随访期间，采用3份标准化问卷一次性评估其吸烟行为。除社会人口统计数据外，还回顾性询问患者在诊断和治疗前后的吸烟习惯和戒烟动机。结果54.8%的参与者在诊断为OSCC前曾尝试过严重戒烟。OSCC诊断后，这一数字上升至82.2%。然而，只有48.5%的人在诊断后成功戒烟。很少使用专业支持的只有21.92% （n = 16）。戒烟动机在确诊前（2.75±2.41）显著低于确诊后（7.27±2.41）（p = 0.001），最终成功戒烟者（9.38±1.68）显著高于继续吸烟者（4.79±3.43）（p = 0.001）。结论OSCC的诊断是戒烟的重要教育时刻。为了最大限度地发挥这一作用，强烈建议在OSCC患者的治疗概念中尽早和标准化地实施系统的戒烟计划。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Dental Research DENTISTRY, ORAL SURGERY & MEDICINE-

CiteScore

3.30

自引率

5.60%

发文量

165

审稿时长

26 weeks

期刊介绍： Clinical and Experimental Dental Research aims to provide open access peer-reviewed publications of high scientific quality representing original clinical, diagnostic or experimental work within all disciplines and fields of oral medicine and dentistry. The scope of Clinical and Experimental Dental Research comprises original research material on the anatomy, physiology and pathology of oro-facial, oro-pharyngeal and maxillofacial tissues, and functions and dysfunctions within the stomatognathic system, and the epidemiology, aetiology, prevention, diagnosis, prognosis and therapy of diseases and conditions that have an effect on the homeostasis of the mouth, jaws, and closely associated structures, as well as the healing and regeneration and the clinical aspects of replacement of hard and soft tissues with biomaterials, and the rehabilitation of stomatognathic functions. Studies that bring new knowledge on how to advance health on the individual or public health levels, including interactions between oral and general health and ill-health are welcome.